Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis | Zendy

Brett R. Loman | Zendy; Diego HernándezSaavedra | Zendy; Ruopeng An | Zendy; R. Scott Rector | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis

Author(s) -

Brett R. Loman,

Diego HernándezSaavedra,

Ruopeng An,

R. Scott Rector

Publication year - 2018

Publication title -

nutrition reviews

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.958

H-Index - 150

eISSN - 1753-4887

pISSN - 0029-6643

DOI - 10.1093/nutrit/nuy031

Subject(s) - nonalcoholic fatty liver disease , medicine , prebiotic , meta analysis , gastroenterology , fatty liver , randomized controlled trial , probiotic , population , disease , biology , food science , genetics , environmental health , bacteria

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent and underdiagnosed comorbidity of many chronic diseases that is associated with altered intestinal bacterial communities. This association has prompted research into alternative treatments aimed at modulating intestinal microbiota. Given the novelty of these treatments, scarce evidence regarding their effectiveness in clinical populations exists.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research